Abstract
Background: It is known that an increased oxidative stress is present in a wide range of diseases and, given the vulnerability of the central nervous system, its involvement has been in particular investigated in neurological and psychiatric diseases, including anxiety disorders.
Objective: In this review, we analyse the studies that have been conducted on the effects of oxidative stress modulators in anxiety, focusing on their possible clinical use.
Discussion and Conclusion: While preclinical studies have shown a clear anxiolytic-like effect of different oxidative stress modulators, less significant results have been obtained from clinical studies. After having reviewed the possible reasons for the discrepancy between preclinical and clinical data, we encourage further studies aimed at better investigating the utility of the modulation of oxidative stress in humans, as an adjunctive therapy of the traditional integrated psychotherapeutic and pharmacological approach.
Keywords: Oxidative stress modulators, anxiety disorders, anxiety models, reactive oxygen species, reactive nitrogen species, lipid peroxidation.
Current Drug Targets
Title:Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
Volume: 19 Issue: 6
Author(s): Paolo Boldrini*, Antonella Fusco, Ferdinando Nicoletti, Aldo Badiani and Luciano Saso
Affiliation:
- Department of Physiology and Pharmacology ,Italy
Keywords: Oxidative stress modulators, anxiety disorders, anxiety models, reactive oxygen species, reactive nitrogen species, lipid peroxidation.
Abstract: Background: It is known that an increased oxidative stress is present in a wide range of diseases and, given the vulnerability of the central nervous system, its involvement has been in particular investigated in neurological and psychiatric diseases, including anxiety disorders.
Objective: In this review, we analyse the studies that have been conducted on the effects of oxidative stress modulators in anxiety, focusing on their possible clinical use.
Discussion and Conclusion: While preclinical studies have shown a clear anxiolytic-like effect of different oxidative stress modulators, less significant results have been obtained from clinical studies. After having reviewed the possible reasons for the discrepancy between preclinical and clinical data, we encourage further studies aimed at better investigating the utility of the modulation of oxidative stress in humans, as an adjunctive therapy of the traditional integrated psychotherapeutic and pharmacological approach.
Export Options
About this article
Cite this article as:
Boldrini Paolo *, Fusco Antonella , Nicoletti Ferdinando , Badiani Aldo and Saso Luciano, Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450118666170425153356
DOI https://dx.doi.org/10.2174/1389450118666170425153356 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multitarget-Directed Ligands: Innovative Chemical Probes and Therapeutic Tools Against Alzheimer's Disease
Current Topics in Medicinal Chemistry Antimicrobial and Anti-MRSA Effects of Three Extracts of Some Hypericum Species Against Standard Microorganisms and Methicillin Resistant Staphylococcus aureus (MRSA) Strains
Current Bioactive Compounds Editorial (Thematic Issue: Synthetic Androgen and New Psycho-Active Compounds (Smart Drugs) Abuse and Dependance. Neuropathological and Toxicological Findings, with an Approach Designed For the Future)
Current Neuropharmacology Cyclodextrins in Nitrosation Chemistry: New Insights of the NO-Transfer Processes
Mini-Reviews in Organic Chemistry Expression and Function of Cytokines and Chemokines in Neuropsychiatric Related Systemic Lupus Erythematosus
Current Rheumatology Reviews In Vivo MR Imaging of the Flow of the Brain Interstitial Fluid
Neuroscience and Biomedical Engineering (Discontinued) Physicochemical and Biological Aspects of Curcumin: A Review
The Natural Products Journal EDITORIAL: Theory of Mind and Mental Health: What the Evidence Suggests so Far?
Current Psychiatry Reviews Can Progression of Alcoholic Liver Disease be Predicted from Certain Biochemical Indices?
Current Nutrition & Food Science Enhanced Transdermal Delivery of Epidermal Growth Factor Facilitated by Dual Peptide Chaperone Motifs
Protein & Peptide Letters Neurosteroids and Hepatic Encephalopathy: An Update on Possible Pathophysiologic Mechanisms
Current Molecular Pharmacology Biomarker Discovery in Clinical Proteomics: Strategies for Exposing Low Abundant Proteins
Current Proteomics A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Current Neuropharmacology Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
Current Alzheimer Research Microwave-assisted Formation of Organic Disulfides of Biochemical Significance
Current Medicinal Chemistry The Multifunctional Mesencephalic Locomotor Region
Current Pharmaceutical Design Pleiotropic Effects of Cytokines on Acute Myocardial Infarction: G-CSF as A Novel Therapy for Acute Myocardial Infarction
Current Pharmaceutical Design New Therapeutic Strategy for Parkinson’s and Alzheimer’s Disease
Current Medicinal Chemistry Hydrogen Sulfide in Physiological and Pathological Mechanisms in Brain
CNS & Neurological Disorders - Drug Targets Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design